TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Derivative Liabilities
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Derivative Liabilities of $276 for the 9-month period ending 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2015-05-15
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in derivative liabilities for the quarter ending 2015-03-31 was -$353.00.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in derivative liabilities for the quarter ending 2014-03-31 was -$29.30K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month |
|---|---|---|---|
| 2015-03-31 | -$353.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $276.00 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $629.00 10-Q · filed 2015-02-12 | ||
| 2014-03-31 | -$29.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $69.39K 10-Q · filed 2015-05-15 | |
| 2013-12-31 | $98.70K 10-Q · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |